Earnings Outlook For West Pharmaceutical Servs
Portfolio Pulse from Benzinga Insights
West Pharmaceutical Servs (NYSE:WST) is set to release its quarterly earnings on October 24, 2024. Analysts expect an EPS of $1.50. The company's past performance shows mixed results, with a recent trend of missing estimates but still experiencing share price increases. Shares are currently down 12.26% over the past year.
October 23, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
West Pharmaceutical Servs is expected to report an EPS of $1.50. Despite past earnings misses, the stock has shown resilience with price increases. Shares are down 12.26% over the past year, indicating potential bearish sentiment among long-term investors.
The upcoming earnings report is crucial for WST as it may influence short-term stock price movements. Despite past EPS misses, the stock has shown resilience, suggesting that positive guidance or surpassing estimates could lead to a price increase. However, the 12.26% decline over the past year indicates some bearish sentiment, which could temper reactions to the earnings announcement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100